# A Phase 2 Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia

> **NCT00664014** · PHASE2 · COMPLETED · sponsor: **Otsuka Beijing Research Institute** · enrollment: 241 (actual)

## Conditions studied

- Hypovolemic Hyponatremia

## Interventions

- **DRUG:** Tolvaptan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00664014
- **Lead sponsor:** Otsuka Beijing Research Institute
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2010-02
- **Final completion:** 2010-02
- **Target enrollment:** 241 (ACTUAL)
- **Last updated:** 2025-03-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00664014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00664014, "A Phase 2 Efficacy and Safety Study of the Tolvaptan Tablets in Patients With Non-hypovolemic Non-acute Hyponatremia". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT00664014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*